SOLESENCE, INC. — Director's Dealing 2017

Feb 22, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOPHASE TECHNOLOGIES Corp (NANX)
CIK: 0000883107
Period of Report: 2017-02-21

Reporting Person: TYLER W EDWIN (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-21	Common Stock (right to buy)	$0.68	A	12000	Acquired	2027-02-21	Common Stock (12000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Common stock (right to buy)	$1.19	2021-01-12	common stock (10000)	10000	Direct
Common stock (right to buy)	$0.30	2022-08-07	common stock (10000)	10000	Direct
Common stock (right to buy)	$0.415	2023-02-14	common stock (12000)	12000	Direct
Common Stock (right to buy)	$0.52	2024-02-13	common stock (12000)	12000	Direct
Common Stock (right to buy)	$0.44	2025-02-18	common stock (10800)	10800	Direct
Common Stock (right to buy)	$0.42	2026-02-23	common stock (9720)	9720	Direct

Footnotes

F1: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.